163 related articles for article (PubMed ID: 22228357)
1. Multiple intraabdominal purulent collections demonstrated on FDG PET/CT in staging of non-Hodgkin lymphoma.
Tow J; Loh H; Bui C; Fuller S; Mansberg R
Clin Nucl Med; 2012 Feb; 37(2):210-3. PubMed ID: 22228357
[TBL] [Abstract][Full Text] [Related]
2. Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT.
Kim DW; Kim WH; Kim CG
Clin Nucl Med; 2013 May; 38(5):e233-5. PubMed ID: 23143046
[TBL] [Abstract][Full Text] [Related]
3. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
4. SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma.
Chang CC; Cho SF; Chen YW; Tu HP; Lin CY; Chang CS
Clin Nucl Med; 2012 Aug; 37(8):e189-95. PubMed ID: 22785526
[TBL] [Abstract][Full Text] [Related]
5. Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer.
Ahmadzadehfar H; Sabet A; Näke K; Hinterthaner B; Biersack HJ; Ezziddin S
Clin Nucl Med; 2009 Mar; 34(3):168-70. PubMed ID: 19352282
[TBL] [Abstract][Full Text] [Related]
6. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
Akkas BE; Vural GU
Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
[TBL] [Abstract][Full Text] [Related]
7. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
8. High liver FDG uptake on PET/CT in patient with lymphoma diagnosed with hereditary hemochromatosis.
Infante JR; Moreno M; Rayo JI; Serrano J; Dominguez ML; Garcia L
Clin Nucl Med; 2015 Jun; 40(6):538-9. PubMed ID: 25608173
[TBL] [Abstract][Full Text] [Related]
9. Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma.
Fonti R; Salvatore B; De Renzo A; Nicolai E; Del Vecchio S
Clin Nucl Med; 2016 Feb; 41(2):169-72. PubMed ID: 26545028
[TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT detection of intussusception caused by lymphoma in a pediatric patient.
Kang HJ; Beylergil V; Price AP; Abramson SJ; Carrasquillo JA
Clin Nucl Med; 2014 Jan; 39(1):97-8. PubMed ID: 24300360
[TBL] [Abstract][Full Text] [Related]
11. Sagittal sinus tumor thrombosis in a case of NHL demonstrated on F-18 FDG PET/CT.
Tripathi M; D'Souza M; Jain J; Kumari R; Guliani S; Pandey SK; Sharma R; Mondal A
Clin Nucl Med; 2011 Mar; 36(3):252-4. PubMed ID: 21285694
[TBL] [Abstract][Full Text] [Related]
12. Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response.
Gykiere P; Jans L; Degrieck B; Goethals I
Clin Nucl Med; 2016 Feb; 41(2):142-3. PubMed ID: 26402124
[TBL] [Abstract][Full Text] [Related]
13. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
[TBL] [Abstract][Full Text] [Related]
14. Deep venous thrombosis on F-18 FDG PET/CT imaging.
Sydow BD; Srinivas SM; Newberg A; Alavi A
Clin Nucl Med; 2006 Jul; 31(7):403-4. PubMed ID: 16785809
[No Abstract] [Full Text] [Related]
15. Peritoneal lymphomatosis found on 18F-FDG PET/CT.
van Rheenen RW; Bongaerts AH; Glaudemans AW
Eur J Haematol; 2012 Dec; 89(6):503-4. PubMed ID: 22712752
[No Abstract] [Full Text] [Related]
16. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
[TBL] [Abstract][Full Text] [Related]
18. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
19. Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma.
Papajík T; Mysliveček M; Sedová Z; Buriánková E; Procházka V; Raida L; Kubová Z; Neoral C; Starostka D; Mikula P; Melichar B; Kučerová L; Tichý M; Indrák K
Clin Nucl Med; 2011 Jul; 36(7):509-12. PubMed ID: 21637049
[TBL] [Abstract][Full Text] [Related]
20. Giant cardiac tumour thrombus on staging contrast enhanced ¹⁸F-FDG PET/CT in a case of non-Hodgkin's lymphoma.
Jeph S; Thakur K; Shamim SA; Verma K; Aggarwal B; Aggarwal A
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):328-9. PubMed ID: 24618093
[No Abstract] [Full Text] [Related]
[Next] [New Search]